FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3197265554> ?p ?o ?g. }

• W3197265554 endingPage "1014" @default.
• W3197265554 startingPage "1002" @default.
• W3197265554 abstract "Immune checkpoint inhibitors target the dysfunctional immune system, to induce cancer-cell killing by CD8-positive T cells. Immune checkpoint inhibitors, specifically anti-CTLA4 and anti-PD-1 antibodies, have revolutionised the management of many cancers, particularly advanced melanoma, for which tumour regression and long-term durable cancer control is possible in nearly 50% of patients, compared with less than 10% historically. Despite the absence of adequately powered trial data, combined anti-CTLA4 and anti-PD-1 checkpoint inhibition has the highest 5-year overall survival rate of all therapies in advanced melanoma, and has high activity in melanoma brain metastases. A phase 3 study has shown the addition of an anti-LAG3 antibody to nivolumab improves progression-free survival, but its effect on overall survival and how this combination compares to combined anti-CTLA4 and anti-PD-1 checkpoint inhibition is unknown. At present, there are no highly sensitive and specific biomarkers of response to immune checkpoint inhibitors, and clinical factors, such as volume and sites of disease, serum lactate dehydrogenase, and BRAF mutation status, are used to select initial therapy for patients with advanced melanoma. Immune checkpoint inhibitors can induce autoimmune toxicities by virtue of their mechanism of action. These toxicities, termed immune-related adverse events, occur most frequently with combined anti-CTLA4 and anti-PD-1 checkpoint inhibition; can have a variety of presentations; can affect any organ system (most often the skin, colon, endocrine system, and liver); and appear to mimic classic autoimmune diseases. Immune-related adverse events require prompt recognition and management, which may be different from the autoimmune disease it mimics. Immune checkpoint inhibitors appear to be safe for use in patients with HIV, viral hepatitis, and patients with mild-to-moderate pre-existing autoimmune diseases. Patients with organ transplants can respond to immune checkpoint inhibitors but have a high chance of transplant loss. PD-1 inhibitors are now an established standard of care as adjuvant therapy in high-risk resected stage III or IV melanoma. Neoadjuvant checkpoint inhibition for resectable stage III melanoma, which is currently limited to clinical trials, is emerging as a highly effective therapy." @default.
• W3197265554 created "2021-09-13" @default.
• W3197265554 creator A5071577704 @default.
• W3197265554 creator A5076054848 @default.
• W3197265554 creator A5083061830 @default.
• W3197265554 date "2021-09-01" @default.
• W3197265554 modified "2023-10-18" @default.
• W3197265554 title "Immune checkpoint inhibitors in melanoma" @default.
• W3197265554 cites W1435076864 @default.
• W3197265554 cites W1834835434 @default.
• W3197265554 cites W1950572133 @default.
• W3197265554 cites W1981197892 @default.
• W3197265554 cites W2007032547 @default.
• W3197265554 cites W2097995306 @default.
• W3197265554 cites W2100158834 @default.
• W3197265554 cites W2103220202 @default.
• W3197265554 cites W2109653150 @default.
• W3197265554 cites W2112601576 @default.
• W3197265554 cites W2123363005 @default.
• W3197265554 cites W2131109593 @default.
• W3197265554 cites W2133075384 @default.
• W3197265554 cites W2143163879 @default.
• W3197265554 cites W2148523692 @default.
• W3197265554 cites W2152897456 @default.
• W3197265554 cites W2153942285 @default.
• W3197265554 cites W2166662937 @default.
• W3197265554 cites W2193769500 @default.
• W3197265554 cites W2296049142 @default.
• W3197265554 cites W2344626562 @default.
• W3197265554 cites W2416791964 @default.
• W3197265554 cites W2491982852 @default.
• W3197265554 cites W2521503673 @default.
• W3197265554 cites W2525217971 @default.
• W3197265554 cites W2529373149 @default.
• W3197265554 cites W2549481046 @default.
• W3197265554 cites W2551317550 @default.
• W3197265554 cites W2553340100 @default.
• W3197265554 cites W2588686192 @default.
• W3197265554 cites W2615188404 @default.
• W3197265554 cites W2620651944 @default.
• W3197265554 cites W2725298133 @default.
• W3197265554 cites W2725988420 @default.
• W3197265554 cites W2736166064 @default.
• W3197265554 cites W2743419024 @default.
• W3197265554 cites W2752227448 @default.
• W3197265554 cites W2760893760 @default.
• W3197265554 cites W2761099324 @default.
• W3197265554 cites W2766903152 @default.
• W3197265554 cites W2767533179 @default.
• W3197265554 cites W2768429453 @default.
• W3197265554 cites W2786396800 @default.
• W3197265554 cites W2786816161 @default.
• W3197265554 cites W2794627893 @default.
• W3197265554 cites W2797309423 @default.
• W3197265554 cites W2808441345 @default.
• W3197265554 cites W2810879984 @default.
• W3197265554 cites W2831487285 @default.
• W3197265554 cites W2885102792 @default.
• W3197265554 cites W2888264184 @default.
• W3197265554 cites W2888298425 @default.
• W3197265554 cites W2891205725 @default.
• W3197265554 cites W2891486030 @default.
• W3197265554 cites W2894313087 @default.
• W3197265554 cites W2894796660 @default.
• W3197265554 cites W2897435840 @default.
• W3197265554 cites W2897815318 @default.
• W3197265554 cites W2899970113 @default.
• W3197265554 cites W2910254477 @default.
• W3197265554 cites W2912137016 @default.
• W3197265554 cites W2912365504 @default.
• W3197265554 cites W2915708315 @default.
• W3197265554 cites W2933124473 @default.
• W3197265554 cites W2946998144 @default.
• W3197265554 cites W2948155539 @default.
• W3197265554 cites W2948740360 @default.
• W3197265554 cites W2949375297 @default.
• W3197265554 cites W2955181150 @default.
• W3197265554 cites W2963476376 @default.
• W3197265554 cites W2963626381 @default.
• W3197265554 cites W2977365200 @default.
• W3197265554 cites W2978554061 @default.
• W3197265554 cites W2989703635 @default.
• W3197265554 cites W2991341799 @default.
• W3197265554 cites W2997720498 @default.
• W3197265554 cites W2999905840 @default.
• W3197265554 cites W3006604655 @default.
• W3197265554 cites W3012088984 @default.
• W3197265554 cites W3015408469 @default.
• W3197265554 cites W3021358555 @default.
• W3197265554 cites W3024460671 @default.
• W3197265554 cites W3033948992 @default.
• W3197265554 cites W3034459487 @default.
• W3197265554 cites W3039168692 @default.
• W3197265554 cites W3043703771 @default.
• W3197265554 cites W3044535623 @default.
• W3197265554 cites W3088619748 @default.
• W3197265554 cites W3089065141 @default.
• W3197265554 cites W3098246733 @default.

• next